Corvus Pharmaceuticals Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Buy

CRVS
Corvus Pharmaceuticals

Last Price:

8.94

Seasonality Move:

-3.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Corvus Pharmaceuticals Stock Forecast

Over the next 52 weeks, Corvus Pharmaceuticals has on average historically risen by 46.2% based on the past 8 years of stock performance.
Corvus Pharmaceuticals has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
Is Corvus Pharmaceuticals Stock Undervalued?
The current Corvus Pharmaceuticals [CRVS] share price is $8.94. The Score for CRVS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
CRVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Corvus Pharmaceuticals Stock Go Up Next Year?

Over the next 52 weeks, Corvus Pharmaceuticals has on average historically risen by 46.2% based on the past 8 years of stock performance.

Corvus Pharmaceuticals Stock Rating

Buy

Corvus Pharmaceuticals (CRVS) is a Buy

Is Corvus Pharmaceuticals overpriced?

Corvus Pharmaceuticals has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%

Corvus Pharmaceuticals Stock Price History

Is CRVS stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRVS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

corvuspharma.com

52-Week Data

52-Week High:

10.00

52-Week Low:

1.30

Prediction Charts

Market Cap:

574.46M

Price in USD:

8.94

Volume:

815.56K

Beta:

1.07

Technical Analysis

SMA50:

7.10

SMA100:

5.13

SMA200:

3.54

52-Wk Change:

538.57%

Stock Predictions

Is Corvus Pharmaceuticals stock public?
Yes, Corvus Pharmaceuticals is a publicly traded company.
What is the Corvus Pharmaceuticals stock quote today?
The Corvus Pharmaceuticals stock price is 8.94 USD today.
How to buy Corvus Pharmaceuticals stock online?
You can buy Corvus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-4	8.99	9.02	9.37	7.91
Nov-5	8.93	9.23	9.44	8.87
Nov-6	9.66	8.78	9.70	8.50
Nov-7	8.67	8.80	9.10	8.43
Nov-8	8.71	9.45	9.61	8.62
Nov-11	9.63	9.56	9.90	9.28
Nov-12	9.40	8.69	9.70	8.67
Nov-13	9.96	8.89	10.00	8.79
Nov-14	8.94	8.52	9.00	7.89
Nov-15	8.40	8.19	8.51	7.78
Nov-18	8.26	8.34	8.71	8.16
Nov-19	8.17	8.40	8.61	8.16
Nov-20	8.34	8.24	8.39	8.02
Nov-21	8.24	8.94	9.05	8.04

Corvus Pharmaceuticals Earnings

Corvus Pharmaceuticals Earnings Report: Per Share Corvus Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Corvus Pharmaceuticals Forecast Revenue Growth

Corvus Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Corvus Pharmaceuticals and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and an increase next year of $0.46 per share.

* Corvus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.